Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

6

Revenue 2017

Remicade

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Remicade was produced by Johnson & Johnson, Mitsubishi Tanabe Pharma and Merck & Co..

J&J files would-be prostate cancer blockbuster in US

J&J files would-be prostate cancer blockbuster in US up and the threat of biosimilar competition to big-selling biologic drugs such as Remicade (infliximab) is becoming ‘more measured’.

Samsung deal with Takeda looks beyond biosimilars

Samsung deal with Takeda looks beyond biosimilars Samsung Bioepis has already been granted approvals for biosimilars of Amgen's Enbrel (etanercept), Johnson &Johnson's Remicade (infliximab) and Sanofi's Lantus (insulin glargine), and has filed for versions of

Merck & Co's Remicade biosimilar undercuts its US rivals

Merck & Co's Remicade biosimilar undercuts its US rivals Pfizer and Celltrion's Inflectra (infliximab-dyyb) biosimilar was priced at a 15% discount to Remicade's $30, 000-a-year price tag. ... alleging patent infringement by the biosimilars, claiming it has IP protecting Remicade out to 2027, and filed a

Biosimilars eat into J&J's Remicade sales

Biosimilars eat into J&J's Remicade sales The group's prescription drug division saw revenues fall 0.2% to $8.6bn, with big-selling immunotherapy Remicade (infliximab) contracting 14% to $1.53bn thanks to the onset of biosimilar ... Currently only Inflectra is available in the US market - which

Standing out in a crowd

Standing out in a crowd It found that swapping from Remicade to a biosimilar version made by Celltrion posed no problems for patients, regardless of the disease for which they were taking the drug. ... patients that could have been switched from Remicade to Celltrion’s

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics